This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Centers for Disease Control and Prevention. CDC https://go.nature.com/3UApbKQ (18 May 2023).
Kostov, Y., Angelone, L., Gutowski, S. & Koustova, E. Subst. Use Misuse 58, 735–738 (2023).
US Food and Drug Administration. FDA https://go.nature.com/4dxYdw9 (2022).
US Food and Drug Administration. FDA https://go.nature.com/4avjNOZ (24 August 2016).
US Food and Drug Administration. FDA https://go.nature.com/3UTVmFd (15 September 2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Angelone, L.M., Capanna, K., Gray, T. et al. Novel medical devices to address the opioid crisis. Nat Med 30, 1805–1806 (2024). https://doi.org/10.1038/s41591-024-03028-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-03028-0